Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus. - Wikidata - wikimedia - TriplyDB

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q41143859

about

Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.Metformin may reduce oral cancer risk in patients with type 2 diabetes Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Metformin use and cervical cancer risk in female patients with type 2 diabetes Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.Enemies or weapons in hands: investigational anti-diabetic drug glibenclamide and cancer risk.Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature.Cancer risk of sulfonylureas in patients with type 2 diabetes mellitus: A systematic review.Use of statins offsets insulin-related cancer risk.Metformin and lung cancer risk in patients with type 2 diabetes mellitus.Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.Metformin: a review of its potential indications.Metformin and endometrial cancer survival: a quantitative synthesis of observational studies.Role of metabolism in cancer cell radioresistance and radiosensitization methods.

P2860

Q26747160-7518E0D9-E7B9-465B-B254-7913D2CFAACE Q36194195-34B92355-2CA9-498F-89AF-B7A222173101 Q36739022-804F59FA-AF55-4404-ACE4-0A8EC62FB161 Q37274957-12A1E23B-B52E-4382-9175-9DFF6BBE15E6 Q37644891-94F9A293-608E-4D09-930A-0BE338CB9D2F Q37745840-E2BE66CE-0D5E-4D20-8285-B6A4A00642F3 Q38765310-95F929C8-C45E-4DD9-8518-7E2FB9AD11ED Q38813996-ACE9F731-A2F2-4355-B5A3-F34A293F04DA Q38858585-53CF0C2D-B127-4495-BEBD-079E4540ACCE Q39263827-D5F51B7E-346E-4F6A-9A80-BFF23E8B358F Q41092838-12B4402E-C386-428E-8393-A9B70318BFB5 Q41111798-27B2F867-FD73-4B3D-BD22-42FBDA1539D7 Q41545473-84583A7C-6AA9-4CBC-A033-B517C2594856 Q42371618-9F026190-E1EC-4269-8155-4713DCF77FA1 Q53692069-66591B68-A24D-44D9-B3B7-C989045B9D53

P2860

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.

http://www.wikidata.org/entity/Q41143859

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.

@en

type

label

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.

@en

prefLabel

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.

@en

P1433

Q41143859-87DE8C97-E480-44C1-993D-F66C0541F277

P1476

Q41143859-40748ACE-E50E-40D1-AB7F-05D7EA73F8F6

P2093

Q41143859-EED9E24C-F1FB-4783-9730-E6ABDFA64D2B

P2860

Q41143859-0735849A-18A6-4E70-B121-A5073B8CA2BA

Q41143859-0DB7AC00-F2E8-4D4A-855C-6B20DCEE3D83

Q41143859-2B828642-9EA7-4B50-BD30-6980C78A6A1E

Q41143859-37A37BEA-19F1-49E8-9DE4-B51F9793BE0C

Q41143859-3D6DEC6D-1552-4489-8B7A-28C006E6CDBD

Q41143859-46008974-2C57-4434-AEBB-F513A536F015

Q41143859-4C828858-11BF-4352-B05C-5E1629ED4C93

Q41143859-500CFD41-4F06-469C-857D-6D213A4A8DD6

Q41143859-51385A8D-DB6B-46FB-AC9C-63ADFFB62A45

Q41143859-55C9E5E8-8757-4DEE-8324-BEC8A9775BF5

P304

Q41143859-19124900-DAB9-430D-8579-239CFDD978D6

P31

Q41143859-8B2A79B3-6352-4167-BBA9-09F7D91B9A70

P356

Q41143859-D44D2CA1-DF1F-46D0-B438-0EB23FF04661

P433

Q41143859-9CAB9B10-5F94-4433-A5F2-1909268EF656

P478

Q41143859-A0E3993E-6908-4C81-BD99-40534E9BDBD8

P50

Q41143859-5C6BDA7B-A4F2-4B1E-AAFE-FA489C309309

P577

Q41143859-9E71EA58-44C8-43A2-935D-C63A4D292776

P698

Q41143859-480FD3C5-E65F-4C39-B29C-5E7BA2C3BFF2

P921

Q41143859-247B7A82-29BE-40C2-8D57-4DA7F4A57A48

Q41143859-7697FC29-3646-4FCC-9AAC-2016F16BC79F

Q41143859-C7586661-4000-4B10-8EAC-D52190B08A75

P356

P1433

Diabetes - Metabolism: Research and Reviews

P1476

Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus

@en

P2093

Chin-Hsiao Tseng

http://www.w3.org/2001/XMLSchema#string

P2860

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies.

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical t

Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort

Pioglitazone and bladder cancer: a population-based study of Taiwanese.

Metformin targets ovarian cancer stem cells in vitro and in vivo.

Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women's Health Study.

Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway.

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner

Human insulin does not increase bladder cancer risk.

P304

619-626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/DMRR.2649

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Chin-Hsiao Tseng

P577

2015-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25820555

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes